Non-Invasive Transcutaneous Bioconductance Measurement as a Risk-Stratification Biomarker for Suspicious Pulmonary Lesions: Results of Plw-216 Prospective, Multi-Center Open Study to Evaluate the Clinical Efficacy and Safety of the Bioconductance Scan Platform (Prolung Test)
2020
Keywords:
-
Correction
-
Source
-
Cite
-
Save
-
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI